Wuhan YZY Biopharma Delays Board Elections for Continuity

Wuhan YZY Biopharma Co., Ltd. Class H (HK:2496) has released an update.

Wuhan YZY Biopharma Co., Ltd. has announced the postponement of its board of directors and supervisory committee elections to ensure continuity in its operations. The current members will continue their duties until the new election is held, which is planned to be completed soon. This delay will not impact the company’s normal operations.

For further insights into HK:2496 stock, check out TipRanks’ Stock Analysis page.